Literature DB >> 29191497

Recontacting in light of new genetic diagnostic techniques for patients with intellectual disability: Feasibility and parental perspectives.

Gea Beunders1, Melodi Dekker1, Oscar Haver1, Hanne J Meijers-Heijboer1, Lidewij Henneman2.   

Abstract

A higher diagnostic yield from new diagnostic techniques makes re-evaluation in patients with intellectual disability without a causal diagnosis valuable, and is currently only performed after new referral. Active recontacting might serve a larger group of patients. We aimed to evaluate parental perspectives regarding recontacting and its feasibility in clinical genetic practice. A recontacting pilot was performed in two cohorts of children with intellectual disability. In cohort A, parents were recontacted by phone and in cohort B by letter, to invite them for a re-evaluation due to the new technologies (array CGH and exome sequencing, respectively). Parental opinions, preferences and experiences with recontacting were assessed by a self-administered questionnaire, and the feasibility of this pilot was evaluated. 47 of 114 questionnaires were returned. In total, 87% of the parents believed that all parents should be recontacted in light of new insights, 17% experienced an (positive or negative) emotional reaction. In cohort A, approached by phone, 36% made a new appointment for re-evaluation, and in cohort B, approached by letter, 4% did. Most parents have positive opinions on recontacting. Recontacting might evoke emotional responses that may need attention. Recontacting is feasible but time-consuming and a large additional responsibility for clinical geneticists.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Duty to recontact; Feasibility; Genetics; Intellectual disability; Patient perspectives

Mesh:

Year:  2017        PMID: 29191497     DOI: 10.1016/j.ejmg.2017.11.017

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

1.  Recontacting clinical genetics patients with reclassified results: equity and policy challenges.

Authors:  Yvonne Bombard; Chloe Mighton
Journal:  Eur J Hum Genet       Date:  2019-04       Impact factor: 4.246

2.  The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.

Authors:  Yvonne Bombard; Kyle B Brothers; Sara Fitzgerald-Butt; Nanibaa' A Garrison; Leila Jamal; Cynthia A James; Gail P Jarvik; Jennifer B McCormick; Tanya N Nelson; Kelly E Ormond; Heidi L Rehm; Julie Richer; Emmanuelle Souzeau; Jason L Vassy; Jennifer K Wagner; Howard P Levy
Journal:  Am J Hum Genet       Date:  2019-04-04       Impact factor: 11.025

Review 3.  Recontacting in medical genetics: the implications of a broadening knowledge base.

Authors:  Shane Doheny
Journal:  Hum Genet       Date:  2021-08-30       Impact factor: 5.881

4.  Recontacting registry participants with genetic updates through GenomeConnect, the ClinGen patient registry.

Authors:  Juliann M Savatt; Danielle R Azzariti; David H Ledbetter; Emily Palen; Heidi L Rehm; Erin Rooney Riggs; Christa Lese Martin
Journal:  Genet Med       Date:  2021-05-18       Impact factor: 8.822

5.  Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics.

Authors:  Daniele Carrieri; Heidi C Howard; Caroline Benjamin; Angus J Clarke; Sandi Dheensa; Shane Doheny; Naomi Hawkins; Tanya F Halbersma-Konings; Leigh Jackson; Hülya Kayserili; Susan E Kelly; Anneke M Lucassen; Álvaro Mendes; Emmanuelle Rial-Sebbag; Vigdís Stefánsdóttir; Peter D Turnpenny; Carla G van El; Irene M van Langen; Martina C Cornel; Francesca Forzano
Journal:  Eur J Hum Genet       Date:  2018-10-11       Impact factor: 4.246

Review 6.  Ethical issues in genomics research on neurodevelopmental disorders: a critical interpretive review.

Authors:  S Mezinska; L Gallagher; M Verbrugge; E M Bunnik
Journal:  Hum Genomics       Date:  2021-03-12       Impact factor: 4.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.